Patient was not fit for Docetaxel therapy and he was put on monthly Denosumab injection 120 mg/1 syringe, and Abiraterone ...

Bone metastases are at the center of advanced prostate cancer care, with over 90% of patients with metastatic prostate cancer expected to have bone involvement. 1 These metastatic ...

Prostate cancer is the second most common cancer affecting men globally, with diagnostic methods and risk assessment ...

which reduces pain and fracture risk Improving progression-free survival and overall survival Reducing the risk of bone metastases from breast cancer and possibly prostate cancer by a third Reducing ...

Explore the role of the extracellular matrix (ECM) in prostate cancer progression and discover natural therapies, including ...

Prostate cancer is one of the most prevalent cancers among men and poses a significant health concern, with its incidence on the rise. In Thailand, it is the 4th most common cancer among men (1), ...

Intravenous; mCRPC: Metastatic castration-resistant prostate cancer; P: Placebo ... the incidence of skeletal-related events (SREs) in bone metastatic CRPC (mCRPC). Denosumab compared with ...

Incontinence can be a side effect of surgery for prostate cancer but can have other causes as well, such as spinal cord compression due to bone metastases. As noted earlier, the bones are the most ...

More men are getting checked for prostate cancer and realising they have the disease at an early stage, but charity Prostate ...

Further tests, such as CT scans and bone scans, may be performed to determine whether prostate cancer has spread. Management strategies for prostate cancer should be guided the severity of the ...

“Our study demonstrates the critical role of PSMA-PET in accurately staging prostate cancer, which can significantly impact treatment decisions and outcomes,” said Jeremie Calais, MD, PhD.